Trial of Thiamine Supplementation in Cambodia

NCT03616288 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 335

Last updated 2021-02-24

No results posted yet for this study

Summary

Beriberi is a potentially fatal disease caused by vitamin B1 (thiamine) deficiency that still occurs in Southeast Asia despite near eradication elsewhere. Mothers with a diet low in thiamine produce thiamine-poor milk, putting their infants at a high risk of developing thiamine deficiency and beriberi. There is also a growing body of evidence suggesting thiamine deficiency not severe enough to cause clinical symptoms may negatively effect cognitive development and functioning of the infant. Since human milk should be the sole source of nutrition for babies during the first six months, maternal thiamine intake must be improved to combat this disease.

The investigators' recent study of thiamine-fortified fish sauce in Cambodia showed that fortification could increase maternal and infant thiamine status'. However, centrally produced fish sauce may not reach the poorest communities who make their own fish sauce, and fish sauce is not consumed in all regions where we find thiamine deficiency. Salt, by contrast, is a common condiment in most regions of the world and has proven to be a successful global fortification vehicle for iodine.

Suboptimal maternal thiamine intake puts exclusively breastfed infants at risk of low thiamine status, impaired cognitive development, and infantile beriberi, which can be fatal. Thiamine fortification of salt is a potentially low-cost and sustainable means of combating suboptimal thiamine status; however knowledge gaps must be filled before thiamine fortification can proceed. In this study, mothers will consume thiamine supplements in order to model the thiamine dose required to optimize human milk thiamine concentrations for the prevention of beriberi. Other thiamine biomarkers will be assessed, and usual salt intake will be measured. Finally, the investigators will assess the effects of early-life thiamine exposure on infant neuro-cognitive development.

Conditions

  • Thiamine Deficiency

Interventions

DIETARY_SUPPLEMENT

thiamine (as thiamine hydrochloride)

Opaque capsules containing varying amounts of thiamine hydrochloride and cellulose filler. All thiamine is delivered as thiamine hydrochloride, calculated using a 1.271 correction factor (ratio of molecular weights of thiamine hydrochloride and thiamine).

Sponsors & Collaborators

  • Sackler Institute for Nutrition Science

    collaborator OTHER
  • Bill and Melinda Gates Foundation

    collaborator OTHER
  • Helen Keller International

    collaborator OTHER
  • NCHADS - Ministry of Health of Cambodia

    collaborator OTHER
  • Ministry of Planning, Cambodia

    collaborator UNKNOWN
  • South Australian Health and Medical Research Institute

    collaborator OTHER
  • Institut de Recherche pour le Developpement

    collaborator OTHER_GOV
  • University of Oregon

    collaborator OTHER
  • Mount Saint Vincent University

    lead OTHER

Principal Investigators

  • Kyly C Whitfield, PhD · Mount Saint Vincent University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-28
Primary Completion
2020-05-05
Completion
2021-01-28

Countries

  • Cambodia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03616288 on ClinicalTrials.gov